After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Vor Biopharma Inc is $94.09M. A total of 0.97 million shares were traded on the day, compared to an average of 756.66K shares.
In the most recent transaction, Attar Eyal C. sold 10,334 shares of VOR for 1.25 per share on Dec 27 ’24. After the transaction, the CHIEF MEDICAL OFFICER now owns 81,439 company shares. In a previous transaction on Dec 27 ’24, EYAL ATTAR bought 10,334 shares at 0.84 per share.
Among the insiders who sold shares, Attar Eyal C. disposed of 14,645 shares on Jun 03 ’24 at a per-share price of $1.39. This resulted in the CHIEF MEDICAL OFFICER holding 96,063 shares of VOR after the transaction.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VOR has a high of $3.14 and a low of $0.63.
As of this writing, VOR has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.36.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VOR’s latest balance sheet shows that the firm has $207.47M in Cash & Short Term Investments as of fiscal 2021. There were $18.01M in debt and $10.15M in liabilities at the time. Its Book Value Per Share was $1.06, while its Total Shareholder’s Equity was $216.26M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VOR is Buy with a score of 5.00.
